Duration of antibiotic therapy in intraabdominal infections;Duración del tratamiento antibiótico en la infección intraabdominal

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue SUPPL. 2, 2010, Pages 49-52

  Maseda, Emilio ^a   Gilsanz, Fernando ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Duration of antibiotic treatment; Intraabdominal infection; Procalcitonin; Secondary peritonitis

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; HUMAN; RISK; TREATMENT DURATION;

ABDOMEN; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; CALCITONIN; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; HUMANS; PRACTICE GUIDELINES AS TOPIC; PROTEIN PRECURSORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEPSIS; SOFT TISSUE INFECTIONS;

EID: 79551550470     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/S0213-005X(10)70030-6     Document Type: Article

References (34)

1. T. Calandra, and J. Cohen The International Sepsis Forum Consensus Conference on definitions of infeccion in the intensive care unit Crit Care Med 33 2005 1538 1548
2. S. Malhotra-Kumar, C. Lammens, S. Coenen, K. Van Herck, and H. Goossens Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study Lancet 369 2007 482 490
3. H.L. Evans, S.N. Lefrak, J. Lyman, R.L. Smith, T.W. Chong, and S.T. McElearney Cost of Gram-negative resistance Crit Care Med 35 2007 89 95
4. D.M. Livermore Has the era of untreatable infections arrived? J Antimicrob Chemother 64 Suppl 1 2009 29 36
5. N. Van de Sande-Bruinsma, H. Grundmann, D. Verloo, E. Tiemersma, J. Monen, and H. Goossens European Antimicrobial Resistance Surveillance System Group; European Surveillance of Antimicrobial Consumption Project Group. Antimicrobial drug use and resistance in Europe Emerg Infect Dis 14 2008 1722 1730
6. S. Coenen, M. Ferech, F.M. Haaijer-Ruskamp, C.C. Butler, R.H. Vander Stichele, and T.J. Verheij ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe Qual Saf Health Care 16 2007 440 445
7. R.H. Vander Stichele, M.M. Elseviers, M. Ferech, S. Blot, and H. Goossens European Survaillance of Antibiotic Comsuption (ESAC) Project Group. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002) J Antimicrob Chemother 58 2006 159 167
8. M.M. Neuhauser, R.A. Weinstein, R. Rydman, L.H. Danziger, G. Karam, and J.P. Quinn Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use JAMA 289 2003 885 888
9. P.M. Lepper, E. Grusa, H. Reichl, J. Högel, and M. Trautmann Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 46 2002 2920 2925
10. M.H. Jeon, S.H. Choi, Y.G. Kwak, J.W. Chung, S.O. Lee, and J.Y. Jeong Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients Diagn Microbiol Infect Dis 62 2008 402 406
11. P.J. Dennesen, A.J. Van der Ven, A.G. Kessels, G. Ramsay, and M.J. Bonten Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia Am J Respir Crit Care Med 163 2001 1371 1375
12. J. Chastre, M. Wolff, J.Y. Fagon, S. Chevret, F. Thomas, and D. Wermert Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial JAMA 290 2003 2588 2598
13. E.H. Ibrahim, S. Ward, G. Sherman, R. Schaiff, V.J. Fraser, and M.H. Kollef Experience with a clinical guideline for the treatment of ventilator-associated pneumonia Crit Care Med 29 2001 1109 1115
14. L.M. Dunbar, R.G. Wunderink, M.P. Habib, L.G. Smith, A.M. Tennenberg, and M.M. Khashab High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm Clin Infect Dis 37 2003 752 760
15. K.G. Kyriakidou, P. Rafailidis, D.K. Matthaiou, S. Athanasiou, and M.E. Falagas Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials Clin Ther 30 2008 1859 1868
16. D.E. Karageorgopoulos, P.E. Valkimadi, A. Kapaskelis, P.I. Rafailidis, and M.E. Falagas Short versus long duration of antibiotic therapy for bacterial meningitis: a meta-analysis of randomised controlled trials in children Arch Dis Chile 94 2009 607 614
17. B.A. Runyon, J.G. McHutchison, M.R. Antillon, E.A. Akriviadis, and A.A. Montano Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients Gastroenterology 100 1991 1737 1742
18. M. Schein, A. Assalia, and H. Bachus Minimal antibiotic therapy after emergency abdominal surgery: a prospective study Br J Surg 81 1994 989 991
19. A. Basoli, P. Chirletti, E. Cirino, N.G. D'Ovidio, G.B. Doglietto, and D. Giglio A prospective, double-blind, multicenter,randomized trial comparing ertapenem 3 vs. ≥ 5 días in community-acquired intraabdominal infection J Gastrointest Surg 12 2008 592 600
20. E.S. Lennard, B.H. Minshew, E.P. Dellinger, and M. Wertz Leukocytosis at termination of antibiotic therapy: its importance for intra-abdominal sepsis Arch Surg 115 1980 918 921
21. E.S. Lennard, E.P. Dellinger, M.J. Wertz, and B.H. Minshew Implications of leukocytosis and fever at conclusion of antibiotic therapy for intra-abdominal sepsis Ann Surg 195 1982 19 24
22. E. Taylor, V. Dev, D. Shah, J. Festekjian, and F. Gaw Complicated appendicitis: is there a minimum intravenous antibiotic requirement? A prospective randomized trial Am Surg 66 2000 887 890
23. F. Alcocer, E. López, J.J. Calva, and M.F. Herrera Antibiotic therapy in secondary peritonitis: towards a definition of its optimal duration Rev Invest Clin 53 2001 121 125
24. E. Maseda, M. Lillo, L. Fernández, M.J. Villagrán, A. Gómez-Rice, and F. Ramasco Septic shock due to community-acquired complicated intra-abdominal infection treated with ertapenem: outcome in 25 cases Rev Esp Anestesiol Reanim 55 2008 227 231
25. J.S. Solomkin, J.E. Mazuski, J.S. Bradley, K.A. Rodvold, E.J. Goldstein, and E.J. Baron Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America Clin Infect Dis 50 2010 133 164
26. X. Guirao, J. Arias, J.M. Badía, J.A. García- Rodríguez, J. Mensa, and F. Álvarez-Lerma Recommendations in the empiric anti-infective agents of intra-abdominal infection Rev Esp Quimioter 22 2009 151 172
27. B. Uzzan, R. Cohen, P. Nicolas, M. Cucherat, and G.Y. Perret Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis Crit Care Med 34 2006 1996 2003
28. K.L. Becker, R. Snider, and E.S. Nylen Procalcitonin assay in systemic inflammation, infection, and sepsis: clinicalutility and limitations Crit Care Med 36 2008 941 952
29. V. Nobre, S. Harbarth, J.D. Graf, P. Rohner, and J. Pugin Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial Am J Respir Crit Care Med 177 2008 498 505
30. P. Schuetz, M. Christ-Crain, R. Thomann, C. Falconnier, M. Wolbers, and I. Widmer Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial JAMA 302 2009 1059 1066
31. D. Stolz, N. Smyrnios, P. Eggimann, H. Pargger, N. Thakkar, and M. Siegemund Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study Eur Respir J 34 2009 1364 1375
32. B. Rau, C.M. Kruger, and M.K. Schilling Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis Langenbecks Arch Surg 389 2004 134 144
33. M. Hochreiter, T. Köhler, A.M. Schweiger, F.S. Keck, B. Bein, and T. Von Spiegel Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial Crit Care 13 2009 R83
34. L. Bouadma, C.E. Luyt, F. Tubach, C. Cracco, A. Álvarez, and C. Schwebel Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial Lancet 375 2010 433 524